Glenmark Pharmaceuticals lost 2.13% to Rs 565 at 10:06 IST on BSE, with the stock sliding after recent rally triggered by the firm's step down subsidiary receiving final abbreviated new drug approvals from the USFDA for two generic drugs. Meanwhile, ... India Infoline, 1 day ago
Glenmark Pharma hits 52-week high - India Infoline, 2 days ago
Glenmark Pharma scales 52-week high - India Infoline, 3 days ago
See all (26) images for "glenmark pharmaceuticals"
Glenmark Pharmaceuticals Ltd today said its subsidiary has received approval from the US health regulator to sell generic versions of AstraZeneca's Zomig and Zomig ZMT tablets, a migraine drug, in the American market.Business Standard, 3 days ago Glenmark gets USFDA approval for headache drug Economic Times, 3 days ago Glenmark Pharma's arm receives final ANDA approvals for Zolmitriptan Tablets from USFDA Indian-Commodity, 3 days ago Glenmark gets USFDA nod for Zolmitriptan tablets Myiris, 3 days ago
Brokerage house FinQuest Securities has maintained its 'Hold' rating on Glenmark Pharmaceuticals with a price target Rs 536, in its May 13, 2013 research report. The stock is fairly valued at the current price and there is limited room for further upside.Money Control, 5 days ago Glenmark may touch Rs 600: JP Morgan Economic Times, 1 week ago
Glenmark Pharmaceuticals at the meeting of the board of directors held on May 07, 2013, Mr. Marshall Mendonza - Vice President Company Secretary ceased to be the Company Secretary of the Company consequent to his retirement. At the same meeting, Mr. Sanjay ...Money Control, 1 week ago Glenmark Pharmaceuticals Appoints Company Secretary & Compliance Officer HDFC Securities, 1 week ago
Vijay told CNBC-TV18, Glenmark is a buy on all declines. It is one of the best pharma stocks in the country. If you look at their business model it is so complete, whether it is new drug discoveries, whether its domestic delivery in the formulations ...Moneycontrol.com, 1 week ago Sharekhan recommends 'buy' on Glenmark, target Rs 600 Smart Investor, 1 week ago Buy Glenmark Pharma, says Sudarshan Sukhani Moneycontrol.com, 1 month ago Sharekhan maintains BUY rating on Glenmark Pharma Smart Investor, 1 month ago
Glenmark Pharmaceuticals Ltd has announced that the Board of Directors of the Company at its meeting held on May 07, 2013, has recommended Dividend @ 200% i.e. Rs. 2/- per share (face value Re. 1/-) on the Equity Share Capital of the Company for the ...India Infoline, 1 week ago Glenmark Pharmaceuticals recommends dividend Money Control, 1 week ago Glenmark Pharmaceuticals FY13 results on May 07, 2013 Money Control, 3 weeks ago Glenmark Pharmaceuticals to announce FY13 results on May 07, 2013 Equity Bulls, 3 weeks ago
Glenmark Pharmaceuticals is well on its way to becoming a large-cap stock, believe analysts.Business Standard, 1 week ago
MUMBAI: Glenmark Pharmaceuticals is likely to report a net profit of Rs 160 crore, up 7 per cent, for the quarter four compared to a net profit of Rs 150 crore in year-ago period, says an . The company's revenues are seen growing 20 per cent to Rs ...Economic Times, 1 week ago Glenmark Pharma Q4 PAT seen at Rs 160 cr Economic Times, 1 week ago
Glenmark Pharmaceuticals Ltd could miss January-March earnings consensus forecast, according to Thomson Reuters StarMine data. StarMine's SmartEstimates, which places greater emphasis on forecastsSify, 1 week ago Starmine data predicts Glenmark profit may miss estimates First Post.com, 1 week ago Glenmark profit may miss estimates: StarMine NDTV Profit, 1 week ago MARKET EYE-Glenmark profit may miss estimates - StarMine CNBC, 1 week ago
More from: , Business Standard...and 6 other sources
The Delhi High Court on Friday sought response of Glenmark Pharmaceuticals on US drug major Merck Sharp and Dohme's appeal against the single judge bench order refusing to restrain the Indian firm from manufacturing and selling anti-diabetes drugs ...BioSpace, 1 month ago Court asks Glenmark to respond in patent row with Merck Business Standard, 1 month ago Drug patent row: High court to hear plea of US firm on Apr 12 MSN.co.in, 1 month ago Drug Patent Row: HC to Hear Merck's Plea on April12 Outlook, 1 month ago
on your WebpageAdd Widget >Get your members hooked!